NDC 47781-380

Pregabalin Extended Release

Pregabalin

Pregabalin Extended Release is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Alvogen Inc.. The primary component is Pregabalin.

Product ID47781-380_7bb60ea1-b02e-e3a3-f2e2-d5a78f25c978
NDC47781-380
Product TypeHuman Prescription Drug
Proprietary NamePregabalin Extended Release
Generic NamePregabalin
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2021-04-14
Marketing CategoryANDA /
Application NumberANDA211593
Labeler NameAlvogen Inc.
Substance NamePREGABALIN
Active Ingredient Strength165 mg/1
DEA ScheduleCV
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 47781-380-30

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47781-380-30)
Marketing Start Date2021-04-14
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Pregabalin Extended Release" or generic name "Pregabalin"

NDCBrand NameGeneric Name
0071-1012LyricaPREGABALIN
0071-1013LyricaPREGABALIN
0071-1014LyricaPREGABALIN
0071-1015LyricaPREGABALIN
0071-1016LyricaPREGABALIN
0071-1017LyricaPREGABALIN
0071-1018LyricaPREGABALIN
0071-1019LyricaPREGABALIN
0071-1020LyricaPREGABALIN

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.